Veradermics
Connecticut Biotech Veradermics Secures $150M for Phase 3 Trials of Oral Rogaine
Veradermics; Connecticut biotech; oral Rogaine; Phase 3 clinical trials; fundraising; hair loss treatment; biotechnology; clinical development
Actionable Insights Powered by AI
Veradermics; Connecticut biotech; oral Rogaine; Phase 3 clinical trials; fundraising; hair loss treatment; biotechnology; clinical development